000			02304cam a2200649 a 4500
005			20150712005446.0
006			m d
007			cr cn
008			091103s2010 nyua sb 001 0 eng
020			_a9780849377853
020			_a0849377854 (hardcover : alk. paper)
020			_a9781420020021 (electronic bk.)
020			_a9781420020021
040			_aCaNSHNOV _beng
050	0	0	_aRS55.2 _b.G454 2010
050		4	_aRS55.2 .G454 2010
060	1	0	_aW1 _bK G
060	1	0	_aQV 38 _bG3255 2010
082	0	0	_a615.19
082	0	0	_a615.19 _222
084			_a615.19 _bK G
100	1		_aKanfer,Isadore
245	1	0	_aGeneric drug product development _h[[Book] :] _bInternational regulatory requirements for bioequivalence / _cIsadore Kanfer, Leon Shargel.
260			_aNew York : _bInforma Healthcare, _cc2010.
300			_axxi, 309 p. : _bill. ; _c24 cm.
490	1		_aDrugs and the pharmaceutical sciences ; _v201
504			_aIncludes bibliographical references and index.
520			_aDiscusses the worldwide legislative and regulatory requirements for the registration of generic and multi-source drug products.
530			_aPrint version also available.
538			_aMode of access: Internet
650		0	_aGeneric drugs.
650		0	_aGeneric drugs _xLaw and legislation.
650	1	2	_aDrugs, Generic _xpharmacokinetics.
650	1	2	_aDrugs, Generic _xstandards.
650	2	2	_aBiological Availability.
650	2	2	_aDrug Design.
650	2	2	_aInternational Cooperation.
650	2	2	_aLegislation, Drug.
650	2	2	_aTherapeutic Equivalency.
650		4	_aBiological availability.
650		4	_aDrug design.
650		4	_aDrugs, Generic -- Pharmacokinetics.
650		4	_aDrugs, Generic -- Standards.
650		4	_aGeneric drugs -- Law and legislation.
650		4	_aGeneric drugs.
650		4	_aInternational cooperation.
650		4	_aLegislation, drug.
650		4	_aTherapeutic equivalency.
650		4	_aPharmacy.
650		4	_aMedicine.
700	1		_aShargel, Leon, _d1941-
700	1		_aKanfer, Isadore.
856	4	1	_uhttp://ezproxy.library.dal.ca/login?url=http://informahealthcare.com/isbn/978-1-4200-2002-1 _yCheck for Full Text _zAccess restricted: Dal users only.
001			0000078397
003			0000
942			_cBK
999			_c51570 _d51570